Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1985 5
1986 27
1987 29
1988 22
1989 55
1990 36
1991 40
1992 35
1993 33
1994 33
1995 25
1996 16
1997 18
1998 29
1999 16
2000 12
2001 19
2002 12
2003 12
2004 4
2005 13
2006 14
2007 20
2008 15
2009 16
2010 19
2011 21
2012 20
2013 35
2014 30
2015 16
2016 21
2017 22
2018 22
2019 14
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

745 results
Results by year
Filters applied: . Clear all
Page 1
Cefixime.
Long SS. Long SS. Pediatr Ann. 1993 Mar;22(3):177-81, 185-6. doi: 10.3928/0090-4481-19930301-08. Pediatr Ann. 1993. PMID: 8464649 Review. No abstract available.
Fixed Drug Eruption Related to Cefixime in an Adolescent Case.
Kulhas Celik İ, Buyuktiryaki B, Misirlioglu ED, Hasbek E, Kocabas CN. Kulhas Celik İ, et al. J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1742-1743. doi: 10.1016/j.jaip.2017.12.004. Epub 2018 Jan 12. J Allergy Clin Immunol Pract. 2018. PMID: 29339130 No abstract available.
Cefixime-induced hepatotoxicity.
Yilmaz B, Ekız F, Coban S, Yüksel I, Yüksel O. Yilmaz B, et al. Turk J Gastroenterol. 2011 Aug;22(4):445. doi: 10.4318/tjg.2011.0297. Turk J Gastroenterol. 2011. PMID: 21948584 Free article. No abstract available.
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors.
Furman WL, Crews KR, Billups C, Wu J, Gajjar AJ, Daw NC, Patrick CC, Rodriguez-Galindo C, Stewart CF, Dome JS, Panetta JC, Houghton PJ, Santana VM. Furman WL, et al. J Clin Oncol. 2006 Feb 1;24(4):563-70. doi: 10.1200/JCO.2005.03.2847. J Clin Oncol. 2006. PMID: 16446328 Clinical Trial.
745 results
Jump to page
Feedback